Search

everythinglearnresearchcommunity

for

Search:↓

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Electrospun 3D nanofibrous materials show promise for bone regeneration in orthopaedics.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Dental pulp stem cells might not reliably become neurons.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

PRP helps skin heal, possibly through special cells called telocytes.

Certain gene variations increase the risk of alopecia areata in Koreans.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Night shift work disrupts the body's natural clock genes.

Fine wool sheep have more genes for wool quality, while coarse wool sheep have more for skin and muscle traits.

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

PRP therapy helps improve hair growth and is safe for treating hair loss.